Topic · Asthma and respiratory diseases
Most cited papers in Asthma and respiratory diseases
What are the most cited papers in Asthma and respiratory diseases?
The most cited paper in Asthma and respiratory diseases is "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease" (Jørgen Vestbo, Suzanne S. Hurd, Alvar G.N. Agustí et al., 2012), with 16,116 citations. Next come "Standardisation of spirometry" (15,846) and "Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations" (6,032).
Showing 50 of 100 papers. Every paper with more than 1,550 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Jørgen Vestbo, Suzanne S. Hurd, Alvar G.N. Agustí et al. · American Journal of Respiratory and Critical Care Medicine | 9 Aug 2012 | 16,116 |
| 2 | Standardisation of spirometry Martin R. Miller, J. Hankinson, Vito Brusasco et al. · European Respiratory Journal | 29 Jul 2005 | 15,846 |
| 3 | Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations Philip H. Quanjer, Sanja Stanojevic, Tim James Cole et al. · European Respiratory Journal | 27 Jun 2012 | 6,032 |
| 4 | Global Initiative for Chronic Obstructive Lung Disease Lynn B. Gerald, William C. Bailey · Journal of Cardiopulmonary Rehabilitation | Jul 2002 | 5,874 |
| 5 | Hay fever, hygiene, and household size. David Peter Strachan · BMJ | 18 Nov 1989 | 5,108 |
| 6 | Allergic Rhinitis and its Impact on Asthma (ARIA) 2008* Jean Bousquet et al. · Allergy | 7 Mar 2008 | 4,764 |
| 7 | Spirometric Reference Values from a Sample of the General U.S. Population John Hankinson, John R. Odencrantz, Kathleen B. Fedan · American Journal of Respiratory and Critical Care Medicine | 1999 | 4,284 |
| 8 | Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys M. Innes Asher, Stephen Montefort, Bengt Björkstén et al. · The Lancet | Aug 2006 | 4,266 |
| 9 | International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Kian Fan Chung et al. · European Respiratory Journal | 12 Dec 2013 | 3,995 |
| 10 | Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response Philip T. Liu et al. · Science | 23 Feb 2006 | 3,966 |
| 11 | The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease James C. Hogg, Fanny S. F. Chu, Soraya Utokaparch et al. · New England Journal of Medicine | 23 Jun 2004 | 3,801 |
| 12 | Asthma and Wheezing in the First Six Years of Life Fernando D. Martínez, Anne L. Wright, Lynn M. Taussig et al. · New England Journal of Medicine | 19 Jan 1995 | 3,800 |
| 13 | International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods MI Asher, Ulrich Keil, H. ROSS ANDERSON et al. · European Respiratory Journal | Mar 1995 | 3,789 |
| 14 | Allergic Rhinitis and Its Impact on Asthma Jean Bousquet, Paul Van Cauwenberge, Nikolaï Khaltaev · Journal of Allergy and Clinical Immunology | Nov 2001 | 3,577 |
| 15 | M-1/M-2 Macrophages and the Th1/Th2 Paradigm Charles D. Mills, Kristi Kincaid, Jennifer M. Alt et al. · The Journal of Immunology | Jun 2000 | 3,341 |
| 16 | Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary Claus Franz Vogelmeier et al. · American Journal of Respiratory and Critical Care Medicine | Mar 2017 | 3,296 |
| 17 | Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease PETER M. A. CALVERLEY, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine | 21 Feb 2007 | 3,282 |
| 18 | Global strategy for asthma management and prevention: GINA executive summary Eric Donn Bateman, Suzanne S. Hurd, Peter John Barnes et al. · European Respiratory Journal | 31 Dec 2007 | 3,258 |
| 19 | A Self-complete Measure of Health Status for Chronic Airflow Limitation: The St. George's Respiratory Questionnaire Paul Jones, Frances H. Quirk, Chloë M. Baveystock et al. · American Review of Respiratory Disease | Jun 1992 | 3,082 |
| 20 | Development of the asthma control test Robert A. Nathan, Christine A. Sorkness, Mark R. Kosinski et al. · Journal of Allergy and Clinical Immunology | 2004 | 2,939 |
| 21 | Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation Bengt O. Samuelsson · Science | 6 May 1983 | 2,858 |
| 22 | Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma Douglas S. Robinson, Qutayba A. Hamid, Sun Ying et al. · New England Journal of Medicine | 30 Jan 1992 | 2,772 |
| 23 | The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases Jean‐François Bach · New England Journal of Medicine | 18 Sep 2002 | 2,699 |
| 24 | Chronic Obstructive Pulmonary Disease Kate Flavin, Clare M. Morkane, Sarah A. Marsh · Cambridge University Press eBooks | 3 Mar 2018 | 2,697 |
| 25 | Interleukin-13: Central Mediator of Allergic Asthma Marsha A. Wills-Karp, Jackie Luyimbazi, Xueying Xu et al. · Science | 18 Dec 1998 | 2,648 |
| 26 | Psoriasis Wolf‐Henning Boehncke, Michael P. Schön · The Lancet | 26 May 2015 | 2,567 |
| 27 | Development and validation of a questionnaire to measure asthma control Elizabeth F. Juniper, Paul M. O’Byrne, Gordon Henry Guyatt et al. · European Respiratory Journal | Oct 1999 | 2,532 |
| 28 | Inositol phospholipids and cell surface receptor function Robert Hall Michell · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes | Mar 1975 | 2,479 |
| 29 | Asthma phenotypes: the evolution from clinical to molecular approaches Sally E. Wenzel · Nature Medicine | May 2012 | 2,446 |
| 30 | Psoriasis Christopher E.M. Griffiths, April Wang Armstrong, Johann Eli Gudjonsson et al. · The Lancet | Apr 2021 | 2,387 |
| 31 | Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease TERENCE A. R. SEEMUNGAL, Gavin C. Donaldson, ELIZABETH A. PAUL et al. · American Journal of Respiratory and Critical Care Medicine | May 1998 | 2,344 |
| 32 | Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 S. G. O. Johansson, Thomas R.M. Bieber, Ronald Dahl et al. · Journal of Allergy and Clinical Immunology | May 2004 | 2,343 |
| 33 | Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma Héctor Ortega, Mark C. Liu, Ian Douglas Pavord et al. · New England Journal of Medicine | 8 Sep 2014 | 2,339 |
| 34 | Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Joan Bautista Soriano et al. · The Lancet Respiratory Medicine | Jun 2020 | 2,336 |
| 35 | Second symposium on the definition and management of anaphylaxis: Summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium Hugh A. Sampson et al. · Journal of Allergy and Clinical Immunology | Feb 2006 | 2,316 |
| 36 | Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing Dmitry Usoskin, Alessandro Furlan, Saiful Islam et al. · Nature Neuroscience | 24 Nov 2014 | 2,297 |
| 37 | Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects Bengt O. Samuelsson, Sven‐Erik Dahlén, JAN ÅKE LINDGREN et al. · Science | 4 Sep 1987 | 2,253 |
| 38 | Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy George Du Toit, Graham Roberts, Peter H. Sayre et al. · New England Journal of Medicine | 23 Feb 2015 | 2,246 |
| 39 | Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Ian Douglas Pavord, Stephanie Korn, Peter Hugo Howarth et al. · The Lancet | Aug 2012 | 2,238 |
| 40 | A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation Bonnie W. Ramsey, Jane Carolyn Davies, Noel Gerard McElvaney et al. · New England Journal of Medicine | 2 Nov 2011 | 2,213 |
| 41 | Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele Peter Gordon Middleton et al. · New England Journal of Medicine | 31 Oct 2019 | 2,211 |
| 42 | Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP Vassili Soumelis, Pedro Antonio Reche, Holger Kanzler et al. · Nature Immunology | 10 Jun 2002 | 2,186 |
| 43 | Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program Wendy C. Moore et al. · American Journal of Respiratory and Critical Care Medicine | 5 Nov 2009 | 2,152 |
| 44 | Global burden of COPD: risk factors, prevalence, and future trends David M. Mannino, A. Sonia Buist · The Lancet | Sep 2007 | 2,131 |
| 45 | Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis Eric Lawrence Simpson et al. · New England Journal of Medicine | Oct 2016 | 2,101 |
| 46 | Psoriasis Pathogenesis and Treatment Adriana Rendón, Knut Schäkel · International Journal of Molecular Sciences | 23 Mar 2019 | 2,090 |
| 47 | Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity Daniel R. Neill, See Heng Wong, Agustin Bellosi et al. · Nature | 3 Mar 2010 | 2,087 |
| 48 | A Large-Scale, Consortium-Based Genomewide Association Study of Asthma Miriam F. Moffatt, Ivo Glynne Gut, Florence Démenais et al. · New England Journal of Medicine | 22 Sep 2010 | 2,069 |
| 49 | Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision Jan Brożek et al. · Journal of Allergy and Clinical Immunology | 8 Jun 2017 | 2,043 |
| 50 | British Guideline on the Management of Asthma British Thoracic Society Scottish Intercollegiate Guidelines Network · Thorax | May 2008 | 2,033 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.